» experimental therapy
-
GlaxoSmithKline signs smoking vaccine licensing agree...
By Escape The Illusion on November 17, 2009 | 2 Comments
Not two months after the Swiss start-up Cytos’s experimental anti-smoking vaccine failed in a mid-stage study, Nabi Biopharmaceuticals (NABI) and GlaxoSmithKline (GSK) have signed a licensing agreement for Nabi’s own anti-smoking vaccine, NicVAX. The deal, which could potentially be wort...
Recent Comments